The introduction of nicotinamide being a nicotine substitute in e-cigarette and smokeless products signifies a major regulatory problem to the FDA. Nicotinamide doesn't have nicotinic receptor agonist activity and is understood to act as a sedative at significant dosages6. The claims made by Nic